FI862370A0 - Monoklonala antikroppar mot cyclosporiner - Google Patents

Monoklonala antikroppar mot cyclosporiner

Info

Publication number
FI862370A0
FI862370A0 FI862370A FI862370A FI862370A0 FI 862370 A0 FI862370 A0 FI 862370A0 FI 862370 A FI862370 A FI 862370A FI 862370 A FI862370 A FI 862370A FI 862370 A0 FI862370 A0 FI 862370A0
Authority
FI
Finland
Prior art keywords
cyclosporins
monoclonal antibodies
cyclosporine
succinimidooxysuccinyl
conjugates
Prior art date
Application number
FI862370A
Other languages
English (en)
Finnish (fi)
Other versions
FI93965C (sv
FI93965B (sv
FI862370A (sv
Inventor
Joachim Rosenthaler
Roland Wenger
Philipp E Ball
Max H Schreier
Valerie Quesniaux
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI862370A0 publication Critical patent/FI862370A0/sv
Publication of FI862370A publication Critical patent/FI862370A/sv
Application granted granted Critical
Publication of FI93965B publication Critical patent/FI93965B/sv
Publication of FI93965C publication Critical patent/FI93965C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
FI862370A 1984-10-04 1986-06-03 Monoklonala antikroppar mot cyclosporiner FI93965C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8425040 1984-10-04
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB8515673 1985-06-20
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds
PCT/EP1985/000501 WO1986002080A1 (en) 1984-10-04 1985-09-27 Monoclonal antibodies to cyclosporings
EP8500501 1985-09-27

Publications (4)

Publication Number Publication Date
FI862370A0 true FI862370A0 (sv) 1986-06-03
FI862370A FI862370A (sv) 1986-06-03
FI93965B FI93965B (sv) 1995-03-15
FI93965C FI93965C (sv) 1995-06-26

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862370A FI93965C (sv) 1984-10-04 1986-06-03 Monoklonala antikroppar mot cyclosporiner

Country Status (15)

Country Link
EP (4) EP0198026B1 (sv)
JP (1) JPH074269B2 (sv)
KR (1) KR910002691B1 (sv)
AT (1) ATE92501T1 (sv)
AU (4) AU589917B2 (sv)
CA (1) CA1309671C (sv)
CY (2) CY1915A (sv)
DE (2) DE3587342T2 (sv)
DK (1) DK172037B1 (sv)
ES (1) ES8702949A1 (sv)
FI (1) FI93965C (sv)
HK (2) HK78696A (sv)
NO (1) NO173557C (sv)
NZ (1) NZ213680A (sv)
WO (1) WO1986002080A1 (sv)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
CA2004626A1 (en) * 1988-12-05 1990-06-05 Bernard F. Erlanger Derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
ATE132504T1 (de) * 1990-08-15 1996-01-15 Abbott Lab Immunotestreagenzien und verfahren zur bestimmung von cyclosporin
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
DE69121844T2 (de) 1990-11-20 1997-01-23 Behringwerke Ag Immunotest für Cyclosporin
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
AU9203898A (en) * 1997-08-26 1999-03-16 Wisconsin Alumni Research Foundation Cyclosporin a conjugates and uses therefor
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
ES2255275T3 (es) 1998-07-01 2006-06-16 Debiopharm S.A. Nueva ciclosporina con perfil de actividad mejorado.
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
WO2000022000A1 (en) * 1998-10-09 2000-04-20 Isotechnika, Inc. Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites
ES2266564T3 (es) 2001-10-19 2007-03-01 Isotechnika Inc. Sintesis de analogos de cicloporinas.
US8288111B2 (en) 2007-05-24 2012-10-16 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
CA2989616A1 (en) * 2008-05-23 2009-11-26 The University Of British Columbia Modified drugs for use in liposomal nanoparticles
NZ594755A (en) 2009-01-30 2013-12-20 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
SG11201601274QA (en) 2013-08-26 2016-03-30 Enanta Pharm Inc Cyclosporin analogues for preventing or treating hepatitis c
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection
EP3247378B8 (en) 2015-01-09 2023-08-23 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
EP4242304A3 (en) * 2015-10-01 2024-02-07 Revolution Medicines, Inc. Methods and reagents for analyzing protein-protein interfaces
JP7187318B2 (ja) 2016-04-12 2022-12-12 ギンゴー バイオワークス， インコーポレイテッド 組換え異種ｌａｌを発現する宿主細胞、及び化合物の生産のための方法
EP3532633A4 (en) 2016-10-28 2020-09-09 Ginkgo Bioworks Inc. COMPOSITIONS AND METHODS OF MAKING COMPOUNDS
KR20220109407A (ko) 2019-11-04 2022-08-04 레볼루션 메디슨즈, 인크. Ras 억제제
CN115873020A (zh) 2019-11-04 2023-03-31 锐新医药公司 Ras抑制剂
AU2020379734A1 (en) 2019-11-04 2022-05-05 Revolution Medicines, Inc. Ras inhibitors
JP2023541916A (ja) 2020-09-15 2023-10-04 レボリューション メディシンズ インコーポレイテッド がんの治療における、ｒａｓ阻害剤としてのインドール誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (sv) 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
DE3167014D1 (en) * 1980-02-14 1984-12-13 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
DE3587505T2 (de) 1994-01-05
EP0290762B1 (en) 1993-05-12
FI93965C (sv) 1995-06-26
EP0198026B1 (en) 1993-08-04
CY1915A (en) 1985-09-27
AU3914389A (en) 1989-11-16
HK78696A (en) 1996-05-10
NZ213680A (en) 1990-05-28
DE3587505D1 (de) 1993-09-09
NO173557B (no) 1993-09-20
KR870700637A (ko) 1987-12-30
DE3587342T2 (de) 1993-12-02
AU4967185A (en) 1986-04-17
CY1927A (en) 1997-05-16
EP0314861A1 (en) 1989-05-10
DE3587342D1 (en) 1993-06-17
NO862177L (no) 1986-08-04
DK261386A (da) 1986-06-03
CA1309671C (en) 1992-11-03
DK261386D0 (da) 1986-06-03
FI93965B (sv) 1995-03-15
DK172037B1 (da) 1997-09-22
EP0290762A1 (en) 1988-11-17
AU589917B2 (en) 1989-10-26
ATE92501T1 (de) 1993-08-15
ES547495A0 (es) 1987-01-16
EP0198026A1 (en) 1986-10-22
JPS62500383A (ja) 1987-02-19
EP0314862A1 (en) 1989-05-10
KR910002691B1 (ko) 1991-05-03
HK124696A (en) 1996-07-19
ES8702949A1 (es) 1987-01-16
NO173557C (no) 1993-12-29
FI862370A (sv) 1986-06-03
NO862177D0 (no) 1986-06-02
JPH074269B2 (ja) 1995-01-25
WO1986002080A1 (en) 1986-04-10
AU3914189A (en) 1989-11-16
AU3914289A (en) 1989-10-26

Similar Documents

Publication Publication Date Title
FI862370A0 (sv) Monoklonala antikroppar mot cyclosporiner
MY104946A (en) Antigen antibody conjugate.
AU1520895A (en) Purified primate ctla-8 antigens and related reagents
ES2091301T3 (es) Inmunoensayo de ciclosporina.
CA2267072A1 (en) Reconstituted human anti-hm1.24 antibody
AU3353589A (en) Integrated scanning tunneling microscope
ES2123677T3 (es) Ligadores de maleinimida trifuncionales homobidentados y su uso en conjugados inmunologicamente activos.
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
IL132380A0 (en) Compositions comprising conjugates of stable active human ob protein with antibody fc chain and methods
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
IL77862A (en) Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit
AU7796291A (en) High affinity antibodies to small peptides
EP0734451A4 (en) ENTEROTOXINS OF -i (SHIGELLA FLEXNERI) 2a
EP1026237A3 (en) Tau/neurofilament protein kinases pk40 & pk36
AU5771798A (en) Antigen
AU2624288A (en) Hiv peptides, artificial hiv antigens and immunoassay kits
NO904742D0 (no) Rekobinant immunogen (antistoff mot membranmolekyler paa antigenpresenterende celler koplet med immunogene peptider).
RO89316A2 (ro) Hibrid triliniar de porumb(zea mays l.convar.indurata)"podu iloaiei 101"

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired